MoonLake Immunotherapeutics (MLTX) KPIs and segments

MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30

$12.50−0.37 (-2.87%)

Close on Nov 13, 2026Market cap $1.06BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive MoonLake Immunotherapeutics's business

Coming soon

This tab will track the numbers specific to MoonLake Immunotherapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?